Corbus Pharmaceuticals Holdings Inc — Quarterly Cash Flow (NASDAQ:CRBP) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Total assets 164.17 M155.88 M139.93 M125.08 M109.51 M Total liabilities 13.67 M13.45 M12.82 M14.09 M17.37 M Total equity 150.5 M142.43 M127.11 M110.99 M92.15 M Total liabilities & shareholders' equities 164.17 M155.88 M139.93 M125.08 M109.51 M Total debt ————— Net debt —————

Haberler

Corbus Pharmaceuticals hisseleri, umut verici obezite ilacı güvenlik verileriyle yükseldi

Corbus Pharmaceuticals stock rises after promising obesity drug safety data

Corbus, obezite ilacı CRB-913 için olumlu faz 1 sonuçlarını açıkladı

Corbus reports positive phase 1 results for obesity drug CRB-913

Corbus, obezite ilacı CRB-913 için faz 1a çalışma sonuçlarını açıklayacak

Corbus to release phase 1a study results for obesity drug CRB-913

Corbus Pharmaceuticals: Data Update, Fundraising Do Not Diminish The Thesis

Corbus Pharmaceuticals: Downgrade To Hold Due To Narrow Focus Window (NASDAQ:CRBP)

Corbus Pharmaceuticals hisseleri 75 milyon dolarlık halka arz sonrası düşüşte

Corbus Pharmaceuticals stock plunges after $75 million public offering

Roku, SPS Commerce, Newell Brands And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Cooper-Standard Holdings (NYSE:CPS), Aptiv (NYSE:APTV)

Corbus, 75 milyon dolarlık halka arz fiyatını belirledi